Trial Profile
To evaluate the humoral immune response to a conjugated pneumococcus vaccine 7-valent (Prevenar) in children from high risk groups
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Oct 2006
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Sponsors Wyeth
- 18 Oct 2006 New trial record.